High-dose imatinib induction followed by standart-dose maintenance in pre-treated chronic phrase chronic myeloid leukemia patients - final analysis of a randomized, multicenter, phrase III trial

Andreas L. Petzer; Stefan Goranov

Б 335

Детайли

Източник

Haematologica

Местоиздаване

Pavia

Година на издаване

2012

Пор.№

Страници

1562-1569

Класификационен индекс

УДК	Значение
616.155.3	Левкопоеза - болести
615.2	Лекарствени средства според основното им действие

Том

Тематична група

Автори от МУ - Пловдив

Допълнителна информация

ISSN: 0390-6078
Системен №: 31580
Тематични рубрики: Хематология
Предметни рубрики: Левкози, Лекарствени средства

Действия

APA Chicago / Turabian (16th edition) Harvard MLA (7th edition) Vancouver

Petzer, A., Goranov, S. High-dose imatinib induction followed by standart-dose maintenance in pre-treated chronic phrase chronic myeloid leukemia patients - final analysis of a randomized, multicenter, phrase III trial. Pavia: 2012 1562-1569,.

Petzer, A., Goranov, S. (2012) High-dose imatinib induction followed by standart-dose maintenance in pre-treated chronic phrase chronic myeloid leukemia patients - final analysis of a randomized, multicenter, phrase III trial, Pavia: 1562-1569,.

Petzer, A., & Goranov, S. (2012). High-dose imatinib induction followed by standart-dose maintenance in pre-treated chronic phrase chronic myeloid leukemia patients - final analysis of a randomized, multicenter, phrase III trial. Haematologica, 97 (10), 1562-1569.

Petzer A, Goranov S. High-dose imatinib induction followed by standart-dose maintenance in pre-treated chronic phrase chronic myeloid leukemia patients - final analysis of a randomized, multicenter, phrase III trial. Haematologica. 2012; 97(10): 1562-1569.